HER-2 Protein Vaccine in Treating Women With Breast Cancer
Clinical trial NCT00068614 · COMPLETED
Trial details
- NCT number
- NCT00068614
- Sponsor
- Case Comprehensive Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2003-07-01
- Primary completion
- 2005-10-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.